Myriad Genetics
MYGN
#7345
Rank
NZ$0.94 B
Marketcap
NZ$9.83
Share price
-2.82%
Change (1 day)
-14.33%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2026 (TTM): -NZ$0.64 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are NZ$0.82 Billion. In 2025 the company made an earning of -NZ$0.71 Billion a decrease over its 2024 earnings that were of -NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.64 Billion-9.01%
2025 -NZ$0.71 Billion218.91%
2024 -NZ$0.23 Billion-53.49%
2023 -NZ$0.48 Billion88.72%
2022 -NZ$0.26 Billion172.08%
2021 -NZ$92.17 Million
2019 -NZ$48.01 Million-175.14%
2018 NZ$63.87 M-70.81%
2017 NZ$0.21 B22.22%
2016 NZ$0.17 B-38.8%
2015 NZ$0.29 B-6.12%
2014 NZ$0.31 B-41.07%
2013 NZ$0.52 B46.67%
2012 NZ$0.36 B15.84%
2011 NZ$0.31 B17.6%
2010 NZ$0.26 B-15.96%
2009 NZ$0.31 B
2007 -NZ$76.07 Million40.96%
2006 -NZ$53.97 Million
2003 -NZ$62.67 Million34.8%
2002 -NZ$46.49 Million89.21%
2001 -NZ$24.57 Million3.93%
2000 -NZ$23.65 Million21.76%
1999 -NZ$19.42 Million-25.61%
1998 -NZ$26.1 Million38.83%
1997 -NZ$18.8 Million-24.26%
1996 -NZ$24.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
NZ$13.17 B-1,969.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-NZ$0.34 Billion-52.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$79.69 M-111.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-NZ$63.82 Million-90.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ$2.40 B-442.02%๐Ÿ‡บ๐Ÿ‡ธ USA